Airbus recorded orders and options for 123 planes, according to the aviation consulting firm IBA.iQ.Paris Air Showread more
Markets in Asia edged up in Tuesday morning trade as investors awaited the start of a closely-watched meeting by the U.S. Federal Reserve, set to kick off later stateside.Asia Marketsread more
Wall Street analysts think Facebook's cryptocurrency payments project will give the company a big boost.Marketsread more
Chinese President Xi Jinping will travel to North Korea this week for a two-day visit, ahead of a possible meeting between Xi and President Donald Trump at next week's G-20...Politicsread more
The Pentagon said that the crew of one of the tankers, the Japanese Kokuka Courageous, found an unexploded limpet mine on its hull following an initial explosion.Politicsread more
Electronic material that Infowars host Alex Jones turned over to families of Sandy Hook Elementary School shooting victims who are suing him contained images of child...Politicsread more
Facebook's reported move into cryptocurrency could amount to the biggest catalyst for digital assets in their decade-long history, some crypto investors say.Bitcoinread more
In a 7-2 ruling, over dissents from Justices Ruth Bader Ginsburg and Neil Gorsuch, the justices affirmed the so-called "dual sovereignty" exception to the Constitution's...Politicsread more
Eleven banks that lend to shipping lines announced Monday that climate impact will be integrated into the criteria that determines how much shipping companies can borrow, an...Transportationread more
Florida businessman Barry Honig agreed to a proposed judgment with the SEC in a case it called "classic pump-and-dump schemes," according to Monday filings.Crimeread more
"The recent Iranian attacks validate the reliable, credible intelligence we have received on hostile behavior by Iranian forces," Shanahan says.Politicsread more
A failed attempt to market iQOS as safer than cigarettes could still be a win for Philip Morris International, says a former FDA official.
PMI wants to claim that using its heat-not-burn tobacco product, iQOS, is safer than smoking cigarettes. An independent committe voted on whether evidence backs PMI's claims, already striking down a few. These are only recommendations to the FDA, and the agency is not required to follow them.
Marc Scheineson, a partner at Alston & Bird and a former associate commissioner for legislative affairs of the FDA, said there is "little to no chance" the committee will approve PMI's modified-risk tobacco product application because there's not enough data to meet the strict standards.
He pointed to Swedish Match presenting a plethora of clinical data for its product, called snus, yet being denied when it went through the same application process. The FDA later approved Swedish Match's premarket tobacco application.
That could be the roadmap for PMI, Scheineson said. PMI has also applied for premarket tobacco approval, which would allow iQOS to be sold in the U.S. That procedure doesn't include a public hearing, so he said applying for the modified-risk tobacco product designation gives PMI a chance to publicly make its case to consumers and regulators.
"I think that's absolutely what the strategy is here," Scheineson said. "Philip Morris has made the determination that this is good, free publicity. It's covered here in a scientific forum discussing how the new device works and how it's different than e-cigs."
In response to the committee vote, the company released a statement:
Philip Morris International appreciates the open, positive dialogue and the serious consideration the Tobacco Products Scientific Advisory Committee (TPSAC) has shown during the last two days in discussing the complex science presented in our Modified-Risk Tobacco Product (MRTP) application. We are encouraged by the recognition of the risk reduction potential of IQOS that clearly emerged from the statements of the Committee members.
We are confident in our ability to address the valid questions raised by the Committee with the FDA as the review process for our application continues.